These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38687066)

  • 1. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women.
    Ng K; Morais S; Wissing MD; Burchell AN; Tellier P-P; Coutlée F; Waterboer T; El-Zein M; Franco EL
    Microbiol Spectr; 2024 Jun; 12(6):e0022924. PubMed ID: 38687066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
    Safaeian M; Porras C; Schiffman M; Rodriguez AC; Wacholder S; Gonzalez P; Quint W; van Doorn LJ; Sherman ME; Xhenseval V; Herrero R; Hildesheim A;
    J Natl Cancer Inst; 2010 Nov; 102(21):1653-62. PubMed ID: 20944077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
    Robbins HA; Li Y; Porras C; Pawlita M; Ghosh A; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Gonzalez P; Schiller J; Lowy D; Esser M; Matys K; Quint W; van Doorn LJ; Herrero R; Pinto LA; Hildesheim A; Waterboer T; Safaeian M
    BMC Infect Dis; 2014 Mar; 14():120. PubMed ID: 24588945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
    Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M
    Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
    Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.
    Velentzis LS; Sitas F; O'Connell DL; Darlington-Brown J; Egger S; Sinha R; Banks E; Frazer IH; Canfell K
    BMC Infect Dis; 2014 Dec; 14():3861. PubMed ID: 25528152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in London.
    King EM; Mesher D; Sonnenberg P; Linley E; Panwar K; Beddows S; Soldan K; Borrow R; Jit M; Gilson R
    Sex Transm Infect; 2021 Aug; 97(5):382-386. PubMed ID: 33361466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
    Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in HPV immunity among adults without cancer.
    Windon MJ; Waterboer T; Hillel AT; Chien W; Best S; Stewart C; Akst L; Troy T; Bender N; Miles B; Ryan WR; Mandal R; Pitman K; Eisele DW; Fakhry C; D'Souza G
    Hum Vaccin Immunother; 2019; 15(7-8):1935-1941. PubMed ID: 30650013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
    Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
    EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
    Vink MA; Berkhof J; van de Kassteele J; van Boven M; Bogaards JA
    PLoS One; 2016; 11(8):e0161109. PubMed ID: 27537200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study.
    Morais S; Wissing MD; Khosrow-Khavar F; Burchell AN; Tellier PP; Coutlée F; Waterboer T; El-Zein M; Franco EL
    J Infect Dis; 2023 May; 227(10):1173-1184. PubMed ID: 36322543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
    Ortiz AP; Tortolero-Luna G; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Suárez E; Palefsky JM; Panicker G; Unger ER
    Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
    Gray P; Kann H; Pimenoff VN; Eriksson T; Luostarinen T; Vänskä S; Surcel HM; Faust H; Dillner J; Lehtinen M
    PLoS Med; 2021 Jun; 18(6):e1003588. PubMed ID: 34097688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of human papillomavirus 6, 11, 16, and 18 in young primiparous women in Sao Paulo, Brazil.
    Rama CH; Villa LL; Pagliusi S; Andreoli MA; Costa MC; Thomann P; Longatto-Filho A; Eluf-Neto J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1405-10. PubMed ID: 21051985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
    Coseo SE; Porras C; Dodd LE; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2011 Oct; 38(10):976-82. PubMed ID: 21934576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-vaccination HPV seroprevalence among female sexual health clinic attenders in England.
    Mesher D; Thomas SL; Linley E; Edmundson C; Checchi M; Waterboer T; Bender N; Müller M; Beddows S; Borrow R; Soldan K
    Vaccine; 2021 Jul; 39(30):4210-4218. PubMed ID: 34127297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
    Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
    BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.
    Mehta PA; Sauter S; Zhang X; Davies SM; Wells SI; Myers KC; Panicker G; Unger ER; Butsch Kovacic M
    Vaccine; 2017 Dec; 35(48 Pt B):6712-6719. PubMed ID: 29042204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.